Neurologic Medication Costs in a Direct-to-Consumer Pharmacy vs Commercial Insurance Plans.

ABSTRACT:

Importance

Given increasing costs of neurologic medications, there is a need to explore alternative options to minimize medication spending.

Objective

To compare 2024 neurologic medication costs from commercial insurance plans with those available in the Mark Cuban Cost Plus Drug Company, a direct-to-consumer pharmacy.

Design, setting, and participants

This cross-sectional study compared medication costs through a direct-to-consumer pharmacy with model-estimated 2024 costs from commercial and Medicare supplemental databases. Commercial insurance plan costs from 2012 to 2021 were used. The direct-to-consumer pricing for each medication was obtained from the website on December 10, 2024.

Main outcomes and measures

The difference between direct-to-consumer and ove

SUBMITTER: Gusovsky Chevalier AV 

PROVIDER: S-EPMC12365698 | biostudies-literature | 2025 Aug

REPOSITORIES: biostudies-literature